Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-048704

President and CEO sold 11,418 shares at an average $14.65 ($167,246)

  • President and CEO acquired 11,418 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Chan Phillip P. President and CEO 2018-09-05 Option exercise +600 $2.00 $1,200 438,881 D
Chan Phillip P. President and CEO 2018-09-05 Option exercise +5,187 $2.10 $10,893 444,068 D
Chan Phillip P. President and CEO 2018-09-06 Option exercise +2,900 $2.10 $6,090 446,968 D
Chan Phillip P. President and CEO 2018-09-07 Option exercise +2,731 $2.10 $5,735 449,699 D
Chan Phillip P. President and CEO 2018-09-05 Sale −600 $14.85 $8,910 449,099 D
Chan Phillip P. President and CEO 2018-09-05 Sale −5,187 $14.85 $77,027 443,912 D
Chan Phillip P. President and CEO 2018-09-06 Sale −2,900 $14.75 $42,775 441,012 D
Chan Phillip P. President and CEO 2018-09-07 Sale −2,731 $14.11 $38,534 438,281 D
Derivatives
Chan Phillip P. President and CEO 2018-09-05 Option exercise · Non-Statutory Stock Option (right to buy) +600 0 D
Chan Phillip P. President and CEO 2018-09-05 Option exercise · Non-Statutory Stock Option (right to buy) +5,187 94,968 D
Chan Phillip P. President and CEO 2018-09-06 Option exercise · Non-Statutory Stock Option (right to buy) +2,900 92,068 D
Chan Phillip P. President and CEO 2018-09-07 Option exercise · Non-Statutory Stock Option (right to buy) +2,731 89,337 D
Open-market sales · 11,418 sh · avg $14.65 · $167,246
Loading xslF345X03/tv502605_4.xml…